(en) Minoo Mohraz, Katayoun Vahdat, Seyyed-Hadi Ghamari et Mohsen Abbasi-Kangevari, « Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial », BMJ, vol. 382, , e070464 (ISSN1756-1833, PMID37734752, DOI10.1136/bmj-2023-070464, lire en ligne, consulté le )
doi.org
dx.doi.org
(en) Minoo Mohraz, Katayoun Vahdat, Seyyed-Hadi Ghamari et Mohsen Abbasi-Kangevari, « Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial », BMJ, vol. 382, , e070464 (ISSN1756-1833, PMID37734752, DOI10.1136/bmj-2023-070464, lire en ligne, consulté le )
doi.org
Abdoli, « Safety and Potency of COVIran Barekat Inactivated Vaccine Candidate for SARS-CoV-2: A Preclinical Study », A Preclinical Study. bioRxiv, (lire en ligne).